<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03962179</url>
  </required_header>
  <id_info>
    <org_study_id>19-053</org_study_id>
    <nct_id>NCT03962179</nct_id>
  </id_info>
  <brief_title>Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent)</brief_title>
  <acronym>VACStent</acronym>
  <official_title>VAC Stent: A Prospective Feasibility Study for the Treatment of Gastrointestinal Leakage Through a Combination of Covered Nitinol Stent and Negative Pressure Wound Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Cologne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open, prospective, one-arm feasibility and efficacy study of a European conformity (CE)
      certified Combination product of two CE certified medical devices in the intended indication.

      Evaluation of the suitability of the medical device for sealing leaks in the gastrointestinal
      tract
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators analyzed the outcome of using a hybrid medical device (self-expanding metal
      stents (SEMS) with negative pressure wound therapy) in the treatment of leaks of the upper
      gastrointestinal tract
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 22, 2019</start_date>
  <completion_date type="Anticipated">November 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 22, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Technique - % of patients with successful implantation of VACStent</measure>
    <time_frame>From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months</time_frame>
    <description>% of patients with successful implantation of VACStent</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Healing of leak - % of patients with successful implantation of VACStent</measure>
    <time_frame>From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months</time_frame>
    <description>% of patients with a sealed leak after successful treatment with VACStent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment of sepsis</measure>
    <time_frame>From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months</time_frame>
    <description>% of patients with successful treatment of sepsis leak after successful implantation of VACStent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Migration rate</measure>
    <time_frame>From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months</time_frame>
    <description>% of patients with migration of VACStent after successful implantation of VACStent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding</measure>
    <time_frame>From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months</time_frame>
    <description>% of patients with bleeding after successful implantation of VACStent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arrosion of tissue structures</measure>
    <time_frame>From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months</time_frame>
    <description>% of patients with % of patients with bleeding after successful implantation of VACStent after successful treatment with VACStent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sealing of leak - % of patients with successful implantation of VACStent</measure>
    <time_frame>From date of first implantation of VACStent until the leak is sealed or the treatment is canceled from any serious medical cause, whichever came first, up to 12 months</time_frame>
    <description>% of patients with a sealed leak after successful treatment with VACStent</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Perforation Esophagus</condition>
  <condition>Esophageal Cancer</condition>
  <condition>Esophageal Achalasia</condition>
  <condition>Esophageal Diseases</condition>
  <arm_group>
    <arm_group_label>VACStent Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient s who received a VACStent</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VACStent</intervention_name>
    <description>Evaluation of the suitability of the medical device for sealing leaks in the gastrointestinal tract</description>
    <arm_group_label>VACStent Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with spontaneous, iatrogenic or postoperative leakage in the esophagus,
             evidence of leakage through an endoscopic examination

          -  Accessibility of the leak with the delivery system of the VAC stent

        Exclusion Criteria:

          -  Simultaneous participation in other interventional exams

          -  Endoscopic inaccessibility of the affected section

          -  Full anticoagulation with international normalized ratio (INR) &gt; 1.5 and / or partial
             thromboplastin time (PTT) &gt; 50 sec, or platelets &lt;20.000 / Î¼l (after therapeutic
             correction an inclusion is possible)

          -  Unstable patients with severe septic disease, who have a clinical history

          -  Assessment an immediate operation for safe focus switch-off requires

          -  Ileus image with constant vomiting (after nasogastric tube and gastric emptying an
             inclusion possible)

          -  Persons who are in a dependency / employment relationship with the sponsor or examiner
             stand

          -  Accommodation in an institution for judicial or regulatory purposes arrangement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seung-Hun Chon, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Cologne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seung-Hun Chon, M.D.</last_name>
    <phone>00492214784864</phone>
    <email>seung-hun.chon@uk-koeln.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christiane Bruns, M.D.</last_name>
    <phone>00492214784801</phone>
    <email>Christiane.bruns@uk-koeln.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Cologne</name>
      <address>
        <city>Cologne</city>
        <state>NRW</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SeungHun Chon, MD</last_name>
      <phone>+49 221 478 4864</phone>
      <email>seung-hun.chon@uk-koeln.de</email>
    </contact>
    <investigator>
      <last_name>Seung-Hun Chon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 21, 2019</study_first_submitted>
  <study_first_submitted_qc>May 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2019</study_first_posted>
  <last_update_submitted>June 22, 2020</last_update_submitted>
  <last_update_submitted_qc>June 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Cologne</investigator_affiliation>
    <investigator_full_name>Seung-Hun Chon</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Perforation Esophagus, Esophageal Anastomotic Leak,</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Achalasia</mesh_term>
    <mesh_term>Esophageal Diseases</mesh_term>
    <mesh_term>Esophageal Perforation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

